BRÈVE publiée le 26/09/2025 à 14:50, il y a 8 mois 27 jours EnVVeno Medical Engages in Virtual Investor Segment Amid FDA Appeal Medical Devices EnVVeno Medical VenoValve Chronic Venous Insufficiency FDA Appeal
COMMUNIQUÉ DE PRESSE publié le 26/09/2025 à 14:45, il y a 8 mois 27 jours enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment enVVeno Medical Corporation announces CEO Robert Berman's participation in a Virtual Investor segment discussing the supervisory appeal for VenoValve® with FDA FDA EnVVeno Medical VenoValve Virtual Investor Supervisory Appeal
BRÈVE publiée le 15/09/2025 à 14:50, il y a 9 mois 8 jours EnVVeno Medical dépose un recours auprès de la FDA EnVVeno Medical Insuffisance Veineuse Chronique Valve VenoValve Appel Auprès De La FDA Processus Réglementaire
BRÈVE publiée le 15/09/2025 à 14:50, il y a 9 mois 8 jours EnVVeno Medical Pursues FDA Supervisory Appeal EnVVeno Medical VenoValve Chronic Venous Insufficiency Regulatory Process FDA Appeal
COMMUNIQUÉ DE PRESSE publié le 15/09/2025 à 14:45, il y a 9 mois 8 jours enVVeno Medical Updates Regulatory Status of VenoValve(R) enVVeno Medical Corporation to file supervisory appeal with FDA regarding not-approvable letter for VenoValve® submission to treat deep venous CVI, aiming to bring innovative solution to patients FDA EnVVeno Medical Corporation VenoValve® Deep Venous Disease Supervisory Appeal
BRÈVE publiée le 20/08/2025 à 13:05, il y a 10 mois 3 jours EnVVeno Medical Receives Not-Approvable Letter from FDA for VenoValve EnVVeno Medical VenoValve FDA Decision Deep Venous Disease Premarket Approval
BRÈVE publiée le 20/08/2025 à 13:05, il y a 10 mois 3 jours EnVVeno Medical reçoit une lettre de non-approbation de la FDA pour VenoValve EnVVeno Medical Valve VenoValve Décision De La FDA Maladie Veineuse Profonde Approbation Préalable À La Mise Sur Le Marché
COMMUNIQUÉ DE PRESSE publié le 20/08/2025 à 13:00, il y a 10 mois 3 jours enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R) enVVeno Medical received a not-approvable letter from the FDA for VenoValve, citing lacking hemodynamic data and safety concerns. Company to work on new criteria and potential resubmission FDA Medical Device EnVVeno Medical VenoValve CVI
BRÈVE publiée le 15/08/2025 à 15:26, il y a 10 mois 8 jours EnVVeno Medical participera à la série de webinaires financiers Webull EnVVeno Medical Valve VenoValve Maladie Veineuse Profonde Webull Financial Biotechnologie/Technologie Médicale
BRÈVE publiée le 15/08/2025 à 15:26, il y a 10 mois 8 jours EnVVeno Medical to Present at Webull Financial Webinar Series EnVVeno Medical VenoValve Deep Venous Disease Webull Financial Biotech/MedTech
Publié le 23/06/2026 à 15:44, il y a 47 minutes Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 15 au 19 juin 2026
Publié le 23/06/2026 à 15:44, il y a 47 minutes Guillemot Corporation S.A. | Weekly report share buyback from June 15 to June 19 2026
Publié le 23/06/2026 à 14:00, il y a 2 heures 31 minutes Neoen remporte un contrat long terme pour une nouvelle batterie de 200 MW / 8 heures en Ontario
Publié le 23/06/2026 à 14:00, il y a 2 heures 31 minutes Neoen awarded long-term contract for new 200 MW / 8-hour battery in Ontario, Canada
Publié le 23/06/2026 à 16:10, il y a 21 minutes Datavault AI Inc. (NASDAQ: DVLT) and WiSA Technologies Announce the Goho LS7 2.0 and 5.1 Home Theater Systems with WiSA E Wireless Connectivity
Publié le 23/06/2026 à 16:00, il y a 31 minutes Secure Blockchain Appoints Former Polygon Executive Steven Bryson-Haynes as CEO to Drive Enterprise AI Commercialization
Publié le 23/06/2026 à 15:45, il y a 46 minutes Amdocs Advances aOS Network Workflows with Live, Multivendor AI-RAN Solution and Industry Blueprint
Publié le 23/06/2026 à 15:30, il y a 1 heure 1 minute Silver Spruce Resources, Inc. Adds Mine Production Knowledge to the Board
Publié le 23/06/2026 à 15:30, il y a 1 heure 1 minute Galantas Gold Completes Transaction to Acquire Andacollo Gold
Publié le 23/06/2026 à 16:20, il y a 10 minutes STRATEC ANNUAL GENERAL MEETING RESOLVES DIVIDEND AND APPROVES ALL PROPOSED RESOLUTIONS
Publié le 23/06/2026 à 16:15, il y a 16 minutes Roubini, Longtime Crypto Skeptic, Co-Authors Whitepaper and Backs Atlas's New Digital Reserve Asset
Publié le 23/06/2026 à 15:50, il y a 41 minutes Vulnerability to Viability: New compact will unlock affordable finance for climate-vulnerable countries
Publié le 23/06/2026 à 15:39, il y a 51 minutes Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2026
